跳转至内容
Merck
CN
  • Dynamic Palmitoylation Targets MAP6 to the Axon to Promote Microtubule Stabilization during Neuronal Polarization.

Dynamic Palmitoylation Targets MAP6 to the Axon to Promote Microtubule Stabilization during Neuronal Polarization.

Neuron (2017-05-19)
Elena Tortosa, Youri Adolfs, Masaki Fukata, R Jeroen Pasterkamp, Lukas C Kapitein, Casper C Hoogenraad
摘要

Microtubule-associated proteins (MAPs) are main candidates to stabilize neuronal microtubules, playing an important role in establishing axon-dendrite polarity. However, how MAPs are selectively targeted to specific neuronal compartments remains poorly understood. Here, we show specific localization of microtubule-associated protein 6 (MAP6)/stable tubule-only polypeptide (STOP) throughout neuronal maturation and its role in axonal development. In unpolarized neurons, MAP6 is present at the Golgi complex and in secretory vesicles. As neurons mature, MAP6 is translocated to the proximal axon, where it binds and stabilizes microtubules. Further, we demonstrate that dynamic palmitoylation, mediated by the family of α/β Hydrolase domain-containing protein 17 (ABHD17A-C) depalmitoylating enzymes, controls shuttling of MAP6 between membranes and microtubules and is required for MAP6 retention in axons. We propose a model in which MAP6's palmitoylation mediates microtubule stabilization, allows efficient organelle trafficking, and controls axon maturation in vitro and in situ.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
抗乙酰化微管蛋白抗体,小鼠单克隆 小鼠抗, clone 6-11B-1, purified from hybridoma cell culture
Roche
抗-GFP, from mouse IgG1κ (clones 7.1 and 13.1)
Sigma-Aldrich
单克隆抗-MAP2 小鼠抗, clone HM-2, purified from hybridoma cell culture
Sigma-Aldrich
抗Tau-1抗体,克隆PC1C6, clone PC1C6, Chemicon®, from mouse
Sigma-Aldrich
抗肌动蛋白抗体,克隆C4, clone C4, Chemicon®, from mouse
Sigma-Aldrich
抗微管蛋白抗体,去酪氨酸化, Chemicon®, from rabbit
Sigma-Aldrich
Pan单克隆抗 钠通道 小鼠抗, ~1 mg/mL, clone K58/35, purified immunoglobulin
Sigma-Aldrich
APT1抑制剂,palmostatin B, The APT1 Inhibitor, palmostatin B controls the biological activity of APT1.